TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108. A total of 139 filers reported holding TARO PHARMACEUTICAL INDS LTD in Q2 2017. The put-call ratio across all filers is 6.53 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $10,000 | -16.7% | 100 | 0.0% | 0.00% | -33.3% |
| Q2 2018 | $12,000 | +20.0% | 100 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $10,000 | 0.0% | 100 | 0.0% | 0.00% | +50.0% |
| Q4 2017 | $10,000 | -9.1% | 100 | 0.0% | 0.00% | -33.3% |
| Q3 2017 | $11,000 | 0.0% | 100 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $11,000 | -8.3% | 100 | 0.0% | 0.00% | -25.0% |
| Q1 2017 | $12,000 | +9.1% | 100 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $11,000 | 0.0% | 100 | 0.0% | 0.00% | -20.0% |
| Q3 2016 | $11,000 | -26.7% | 100 | 0.0% | 0.01% | -16.7% |
| Q2 2016 | $15,000 | – | 100 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ISZO CAPITAL LP | 1,104,068 | $104,886,000 | 77.66% |
| Greywolf Capital Management LP | 472,135 | $46,694,000 | 10.17% |
| Consonance Capital Management LP | 263,732 | $26,083,000 | 4.28% |
| Moab Capital Partners | 83,132 | $8,222,000 | 3.77% |
| Raging Capital Management, LLC | 190,151 | $18,806,000 | 3.45% |
| Valentine Capital Asset Management, Inc. | 145,053 | $14,346,000 | 3.07% |
| Assured Investment Management LLC | 1,353,342 | $133,846,000 | 1.21% |
| Ativo Capital Management LLC | 22,828 | $2,258,000 | 0.99% |
| Perceptive Advisors | 56,602 | $5,598,000 | 0.67% |
| Jaffetilchin Investment Partners, LLC | 7,721 | $764,000 | 0.38% |